Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: A nationwide prospective cohort study

Breast Cancer Research and Treatment

Volumn 144, Issue 1, 2014, Pages 185-192

  Kharazmi, Elham ^a   Chen, Tianhui ^a   Narod, Steven ^b   Sundquist, Kristina ^c,d   Hemminki, Kari ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Cancer Research   (Canada)

^c LUND UNIVERSITY   (Sweden)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age at onset; Contralateral breast cancer; Familial breast cancer; Multiple ipsilateral breast cancers

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE IDENTIFICATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SWEDEN;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84894652217     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2848-3     Document Type: Article

References (34)

1. Evans DG, Lalloo F (2002) Risk assessment and management of high risk familial breast cancer. J Med Genet 39(12):865-871
2. Kharazmi E, Fallah M, Sundquist K, Hemminki K (2012) Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ 345:e8076
3. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98(1):61-68
4. Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81-91
5. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P (2001) The nation-wide Swedish Family Cancer Database: updated structure and familial rates. Acta Oncol 40(6):772-777
6. The National Board of Health and Welfare CfE (2007) Cancer incidence in Sweden 2006
7. Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169-176
8. Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998-1002
9. Dong C, Hemminki K (2001) Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 92(6):883-887
10. Dong C, Hemminki K (2001) Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer 93(2):155-161
11. Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ et al (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330-4336
12. Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404-2410
13. Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887-5892
14. Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328-2335
15. Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka SN et al (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31(4):433-439
16. Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855-861
17. Beckmann KR, Buckingham J, Craft P, Dahlstrom JE, Zhang Y, Roder D, Stuart-Harris R (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158-164
18. Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937-948
19. Hemminki K, Ji J, Forsti A (2007) Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res 67(3):868-870
20. Ji J, Hemminki K (2007) Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105(2):229-236
21. McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624-628
22. Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos SI, Ashworth A, Peto J (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366(9496):1554-1557
23. Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377-382
24. Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A et al (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384-1392
25. Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mutat Res 473(1):11-21
26. Li CI, Malone KE, Weiss NS, Daling JR (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 93(13):1008-1013
27. Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven RM, Hupe P, Hadhri R et al (2012) Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res 18(6):1704-1715
28. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879-1886
29. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception 54(3 Suppl):1S-106S; 1996
30. Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344-350
31. Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9(3):221-236
32. Leu M, Reilly M, Czene K (2008) Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst 100(18):1318-1325
33. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27-33
34. Hemminki K, Mutanen P (2001) Birth order, family size, and the risk of cancer in young and middle-aged adults. Br J Cancer 84(11):1466-1471